About Artivion
Artivion is a company based in Kennesaw (United States) founded in 1984. The company has 1,600 employees as of December 31, 2024. Artivion has completed 1 acquisition, including Endospan. Artivion offers products and services including AMDS Hybrid Prosthesis and ON-X Aortic Heart Valve.
- Headquarter Kennesaw, United States
- Employees 1600 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Artivion, Inc.
-
Annual Revenue
$388.54 M (USD)9.75as on Dec 31, 2024
-
Net Profit
-$13.34 M (USD)56.37as on Dec 31, 2024
-
EBITDA
$51.69 M (USD)36.52as on Dec 31, 2024
-
Latest Funding Round
$250 M (USD), Debt – Conventional
Jan 19, 2024
-
Investors
Ares Management
& 1 more
-
Employee Count
1600
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Artivion
Artivion is a publicly listed company on the NYSE with ticker symbol AORT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Artivion
Artivion offers a comprehensive portfolio of products and services, including AMDS Hybrid Prosthesis and ON-X Aortic Heart Valve.
This device is utilized for treating acute aortic dissections and is recognized as the first aortic arch remodeling tool
This valve is employed in surgical procedures to replace damaged heart valves and improve patient outcomes
People of Artivion
Unlock access to complete
Unlock access to complete
Funding Insights of Artivion
Investors in Artivion
Artivion has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ares Management and Military Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alternative asset investment management firm
|
Locked | Locked | Locked | |
|
Administers health care and support for military personnel and operations.
|
Locked | Locked | Locked |
Investor details for Artivion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Artivion
Artivion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Endospan.
Investment portfolio details for Artivion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Endovascular stent graft systems for aortic aneurysm repair are developed.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Artivion
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Artivion
Detailed financials for Artivion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Artivion Comparisons
Peer comparison for Artivion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Artivion
Detailed competitors of Artivion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Artivion
Complete news archive for Artivion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Artivion
Artivion was founded in 1984 and raised its 1st funding round 26 years after it was founded.
Artivion is headquartered in Kennesaw, United States. It is registered at Kennesaw, Georgia, United States.
J Patrick Mackin is the current CEO of Artivion.
As of Dec 31, 2024, the latest employee count at Artivion is 1,600.
Annual revenue of Artivion is $388.54M as on Dec 31, 2024.
Artivion was founded in 1984 and is headquartered in Kennesaw, United States. Operations center on the medical device sector, where technologies for aortic diseases are developed and supplied. Products include aortic arch stent graft systems, hybrid prostheses, heart valves, surgical sealants and adhesives, cardiac and vascular allografts, and decellularized bovine pericardium. Solutions are provided to cardiac and vascular surgeons for treating patients with aortic conditions.
Artivion offers AMDS Hybrid Prosthesis and ON-X Aortic Heart Valve.
Yes, Artivion is publicly traded on NYSE under the ticker symbol AORT.
Artivion has made 1 acquisition, including Endospan.
Artivion has 2 investors. Key investors include Ares Management, and Military Health.
The ticker symbol of Artivion is AORT on NYSE.